Literature DB >> 31701291

Association of MTHFR gene polymorphisms with pancreatic cancer: meta-analysis of 17 case-control studies.

Fangfang Nie1, Mingli Yu2, Kaili Zhang1, Luping Yang1, Qian Zhang1, Shan Liu1, Mengwei Liu1, Mengke Shang1, Fanxin Zeng1, Wanyang Liu3.   

Abstract

BACKGROUND: Pancreatic cancer (PC) is a seriously malignant tumor with a low 5-year survival rate. The relationship between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and PC has been reported by several studies. However, the results were controversial. Thus, we conducted a meta-analysis to summarize available data on MTHFR gene and PC.
METHODS: We searched PubMed, Embase, Web of Science, Wanfang, CNKI databases prior to July 2019. Data were analyzed by RevMan 5.3 and STATA 12.0 software. Odds ratio (OR) and 95% confidence interval (CI) were used to evaluate the strength of the association. Subgroup analysis, sensitivity analysis and assessment of publication bias were performed in this study.
RESULTS: Ten articles with 17 reports (10 for C677T, 7 for A1298C) were eligible for inclusion in the meta-analysis (1864 cases and 3165 controls for C677T, and 1488 cases and 1946 controls for A1298C). Our meta-analysis detected that C677T was associated with PC for three genetic models (allele model: OR = 1.24, 95% CI: 1.00-1.53, P = 0.047; recessive model: OR = 1.39, 95% CI: 1.04-1.86, P = 0.027; homozygous model: OR = 1.60, 95% CI: 1.04-2.45, P = 0.034). In the stratified analyses according to ethnicity, source of controls and genotyping method, significant association was observed in genotyping method subgroup. For the A1298C polymorphism, no significant association was observed either in overall analysis or in subgroup analysis under all genetic models.
CONCLUSIONS: MTHFR gene C677T rather than A1298C polymorphism may be associated with PC. Larger sample size studies should be performed to find the association between MTHFR gene and PC.

Entities:  

Keywords:  MTHFR gene; Meta-analysis; Pancreatic cancer; Polymorphism

Mesh:

Substances:

Year:  2019        PMID: 31701291     DOI: 10.1007/s10147-019-01571-2

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  44 in total

1.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

2.  Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis.

Authors:  Susanna C Larsson; Edward Giovannucci; Alicja Wolk
Journal:  Gastroenterology       Date:  2006-08-05       Impact factor: 22.682

3.  Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer.

Authors:  Li Wang; Xiaoping Miao; Wen Tan; Xinghua Lu; Ping Zhao; Xiaohang Zhao; Yi Shan; Hui Li; Dongxin Lin
Journal:  Clin Gastroenterol Hepatol       Date:  2005-08       Impact factor: 11.382

4.  Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes.

Authors:  Hiroyuki Matsubayashi; Halcyon G Skinner; Christine Iacobuzio-Donahue; Tadayoshi Abe; Norihiro Sato; Taylor Sohn Riall; Charles J Yeo; Scott E Kern; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2005-08       Impact factor: 11.382

5.  Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017.

Authors:  Aimee L Lucas; Matteo Malvezzi; Greta Carioli; Eva Negri; Carlo La Vecchia; Paolo Boffetta; Cristina Bosetti
Journal:  Clin Gastroenterol Hepatol       Date:  2016-06-03       Impact factor: 11.382

Review 6.  A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.

Authors:  A Carrato; A Falcone; M Ducreux; J W Valle; A Parnaby; K Djazouli; K Alnwick-Allu; A Hutchings; C Palaska; I Parthenaki
Journal:  J Gastrointest Cancer       Date:  2015-09

7.  Association between methylenetetrahydrofolate reductase (MTHFR) polymorphisms and lung cancer risk in Chinese people: An updated meta-analysis.

Authors:  Rui Zhong; Qingling Chen; Xinyue Zhang; Mengmeng Li; Xin Zhang; Weihong Lin
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

8.  Association study between genetic polymorphisms in folate metabolism and gastric cancer susceptibility in Chinese Han population: A case-control study.

Authors:  Lusha Wei; Fanglin Niu; Jiamin Wu; Fulin Chen; Hua Yang; Jing Li; Tianbo Jin; Yifei Wu
Journal:  Mol Genet Genomic Med       Date:  2019-03-18       Impact factor: 2.183

9.  The role of the folate pathway in pancreatic cancer risk.

Authors:  Shirisha Chittiboyina; Zhongxue Chen; E Gabriela Chiorean; Lisa M Kamendulis; Barbara A Hocevar
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

10.  Effect of MTHFR Polymorphisms on Gastrointestinal Cancer Risk in Italy.

Authors:  Federica Mazzuca; Marina Borro; Andrea Botticelli; Laura Aimati; Giovanna Gentile; Carlo Capalbo; Chiara Maddalena; Eva Mazzotti; Maurizio Simmaco; Paolo Marchetti
Journal:  World J Oncol       Date:  2015-08-27
View more
  2 in total

1.  Strong Correlation of MTHFR Gene Polymorphisms with Breast Cancer and its Prognostic Clinical Factors among Egyptian Females.

Authors:  Moataza H Omran; Basma E Fotouh; Wafaa G Shousha; Abeer Ismail; Noha E Ibrahim; Shimaa S Ramadan
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

2.  Meta-analysis of the relationship between methylenetetrahydrofolate reductase C677T and A1298C polymorphism and venous thromboembolism in the Caucasian and Asian.

Authors:  Miao Gao; Na Feng; Meixia Zhang; Xinyu Ti; Xiuping Zuo
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.